These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Comparison of the efficacy of topical insulin with autologous serum eye drops in persistent epithelial defects of the cornea. Diaz-Valle D; Burgos-Blasco B; Rego-Lorca D; Puebla-Garcia V; Perez-Garcia P; Benitez-Del-Castillo JM; Herrero-Vanrell R; Vicario-de-la-Torre M; Gegundez-Fernandez JA Acta Ophthalmol; 2022 Jun; 100(4):e912-e919. PubMed ID: 34407296 [TBL] [Abstract][Full Text] [Related]
5. Therapeutic outcomes of combined topical autologous serum eye drops with silicone-hydrogel soft contact lenses in the treatment of corneal persistent epithelial defects: A preliminary study. Lee YK; Lin YC; Tsai SH; Chen WL; Chen YM Cont Lens Anterior Eye; 2016 Dec; 39(6):425-430. PubMed ID: 27349951 [TBL] [Abstract][Full Text] [Related]
6. Combination of serum eye drops with hydrogel bandage contact lenses in the treatment of persistent epithelial defects. Schrader S; Wedel T; Moll R; Geerling G Graefes Arch Clin Exp Ophthalmol; 2006 Oct; 244(10):1345-9. PubMed ID: 16544115 [TBL] [Abstract][Full Text] [Related]
7. Autologous serum eye drops for the treatment of persistent corneal epithelial defects. Arain MA; Dar AJ; Adeeb L J Coll Physicians Surg Pak; 2013 Oct; 23(10):737-9. PubMed ID: 24112261 [TBL] [Abstract][Full Text] [Related]
8. Topical 100% serum eye drops for treating corneal epithelial defect after ocular surgery. Lekhanont K; Jongkhajornpong P; Choubtum L; Chuckpaiwong V Biomed Res Int; 2013; 2013():521315. PubMed ID: 23984378 [TBL] [Abstract][Full Text] [Related]
9. A study of refractory cases of persistent epithelial defects associated with dry eye syndrome and recurrent corneal erosions successfully treated with cyclosporine A 0.05% eye drops. Napoli PE; Braghiroli M; Iovino C; Demarinis G; Fossarello M Drug Des Devel Ther; 2019; 13():2001-2008. PubMed ID: 31354245 [No Abstract] [Full Text] [Related]
10. Use of Autologous Serum Eye Drops with Contact Lenses in the Treatment of Chemical Burn-Induced Bilateral Corneal Persistent Epithelial Defects. Chen YM; Wang WY; Lin YC; Tsai SH; Lou YT Biomed Res Int; 2022; 2022():6600788. PubMed ID: 35237689 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of topical insulin for recurrent epithelial corneal erosions. Esmail A; Ibrahim M; Nage S Ir J Med Sci; 2023 Dec; 192(6):3117-3123. PubMed ID: 37140764 [TBL] [Abstract][Full Text] [Related]
12. Autologous serum 50% eyedrops in the treatment of persistent corneal epithelial defects. Jeng BH; Dupps WJ Cornea; 2009 Dec; 28(10):1104-8. PubMed ID: 19730088 [TBL] [Abstract][Full Text] [Related]
13. Exploratory Phase II Multicenter, Open-Label, Clinical Trial of ST266, a Novel Secretome for Treatment of Persistent Corneal Epithelial Defects. Jeng BH; Hamrah P; Kirshner ZZ; Mendez BC; Wessel HC; Brown LR; Steed DL Transl Vis Sci Technol; 2022 Jan; 11(1):8. PubMed ID: 34994777 [TBL] [Abstract][Full Text] [Related]
14. Open clinical study of eye-drops containing tetrapeptides derived from substance P and insulin-like growth factor-1 for treatment of persistent corneal epithelial defects associated with neurotrophic keratopathy. Yamada N; Matsuda R; Morishige N; Yanai R; Chikama TI; Nishida T; Ishimitsu T; Kamiya A Br J Ophthalmol; 2008 Jul; 92(7):896-900. PubMed ID: 18511539 [TBL] [Abstract][Full Text] [Related]
15. Open clinical study of eye drops containing the fibronectin-derived peptide PHSRN for treatment of persistent corneal epithelial defects. Yamada N; Morishige N; Yanai R; Morita Y; Kimura K; Chikama T; Nomizu M; Sonoda KH; Nishida T Cornea; 2012 Dec; 31(12):1408-13. PubMed ID: 23135532 [TBL] [Abstract][Full Text] [Related]
17. Undiluted Serum Eye Drops for the Treatment of Persistent Corneal Epitheilal Defects. Lekhanont K; Jongkhajornpong P; Anothaisintawee T; Chuckpaiwong V Sci Rep; 2016 Dec; 6():38143. PubMed ID: 27909310 [TBL] [Abstract][Full Text] [Related]
18. Randomized Clinical Trial of Topical Insulin Versus Artificial Tears for Healing Rates of Iatrogenic Corneal Epithelial Defects Induced During Vitreoretinal Surgery in Diabetics. Dasrilsyah AM; Wan Abdul Halim WH; Mustapha M; Tang SF; Kaur B; Ong EY; Bastion MLC Cornea; 2023 Nov; 42(11):1395-1403. PubMed ID: 37267451 [TBL] [Abstract][Full Text] [Related]
19. Treatment of severe ocular surface disorders with albumin eye drops. Schargus M; Kohlhaas M; Unterlauft JD J Ocul Pharmacol Ther; 2015 Jun; 31(5):291-5. PubMed ID: 25853388 [TBL] [Abstract][Full Text] [Related]
20. Treatment of persistent corneal epithelial defect with extended wear of a fluid-ventilated gas-permeable scleral contact lens. Rosenthal P; Cotter JM; Baum J Am J Ophthalmol; 2000 Jul; 130(1):33-41. PubMed ID: 11004257 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]